SBC Medicals Return on Tangible Equity 2023-2025 | SBC
Current and historical return on tangible equity values for SBC Medicals (SBC) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| SBC Medicals Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $0.05B | $0.22B | 33.11% |
| 2024-12-31 | $0.05B | $0.19B | 47.84% |
| 2024-09-30 | $0.05B | $0.19B | 64.20% |
| 2024-06-30 | $0.06B | $0.01B | 172.73% |
| 2024-03-31 | $0.06B | $0.01B | 193.22% |
| 2023-12-31 | $0.04B | $0.12B | 148.57% |
| 2023-06-30 | $0.00B | $-0.01B | -33.33% |
| 2023-03-31 | $0.00B | $0.00B | -57.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.360B | $0.205B |
| SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $133.694B | 25.08 |
| Elevance Health (ELV) | United States | $90.401B | 11.66 |
| CVS Health (CVS) | United States | $78.570B | 9.77 |
| Cencora (COR) | United States | $56.472B | 19.65 |
| DiDi Global (DIDIY) | China | $22.450B | 34.07 |
| Natera (NTRA) | United States | $20.631B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.588B | 13.33 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.514B | 0.00 |
| CochLear (CHEOY) | Australia | $11.382B | 0.00 |
| Revvity (RVTY) | United States | $10.588B | 18.22 |
| ICON (ICLR) | Ireland | $10.225B | 9.51 |
| Viatris (VTRS) | United States | $9.953B | 3.42 |
| Doximity (DOCS) | United States | $9.475B | 44.13 |
| Avantor (AVTR) | United States | $8.552B | 12.43 |
| HealthEquity (HQY) | United States | $8.545B | 42.04 |
| Medpace Holdings (MEDP) | United States | $8.501B | 22.58 |
| Sonic Healthcare (SKHHY) | Australia | $8.263B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.630B | 12.99 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.137B | 38.29 |
| Bausch + Lomb (BLCO) | Canada | $3.955B | 23.31 |
| Sotera Health (SHC) | United States | $3.503B | 19.90 |
| Alignment Healthcare (ALHC) | United States | $3.033B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.905B | 37.78 |
| Concentras Parent (CON) | United States | $2.803B | 16.20 |
| Organon (OGN) | United States | $2.191B | 2.33 |
| Ardent Health Partners (ARDT) | United States | $2.137B | 9.11 |
| GeneDx Holdings (WGS) | United States | $1.934B | 74.48 |
| Premier (PINC) | United States | $1.899B | 14.41 |
| Progyny (PGNY) | United States | $1.816B | 39.98 |
| PACS (PACS) | United States | $1.506B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.354B | 27.07 |
| Pediatrix Medical (MD) | United States | $1.303B | 9.91 |
| Teladoc Health (TDOC) | United States | $1.223B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.037B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| Agilon Health (AGL) | United States | $0.973B | 0.00 |
| CareDx (CDNA) | United States | $0.949B | 14.83 |
| Nutex Health (NUTX) | United States | $0.941B | 14.21 |
| AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.722B | 4.86 |
| InnovAge Holding (INNV) | United States | $0.554B | 0.00 |
| Enhabit (EHAB) | United States | $0.528B | 43.46 |
| Auna S.A (AUNA) | Luxembourg | $0.506B | 11.40 |
| LifeMD (LFMD) | United States | $0.489B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.403B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.204B | 0.00 |
| Oncology Institute (TOI) | United States | $0.202B | 0.00 |
| Beauty Health (SKIN) | United States | $0.195B | 0.00 |
| KindlyMD (KDLY) | United States | $0.137B | 0.00 |
| DocGo (DCGO) | United States | $0.131B | 21.33 |
| So-Young (SY) | China | $0.089B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.058B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |